Insider · CIK 0001423084

Schall Thomas J.

CIK 0001423084 Name as filed on the most recent filing

Filed as Schall Thomas J. (46)

104 transaction lines · from 46 filings · filed 2012-10-03 to 2026-01-20 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

104 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

Transactions filed by this insider
Direction Date Code Company Value USD Filing
2026-01-15 P, Open-market purchase Immuneering CorpIMRX 101,041, acquired Open Form 4 filing 0001790340-26-000014
2025-06-27 P, Open-market purchase Immuneering CorpIMRX 34,788, acquired Open Form 4 filing 0001790340-25-000089
2025-06-17 P, Open-market purchase Immuneering CorpIMRX 89,278, acquired Open Form 4 filing 0001790340-25-000079
2024-03-22 P, Open-market purchase Immuneering CorpIMRX 7,385, acquired Open Form 4 filing 0001415889-24-009028
2022-08-04 S, Open-market sale ChemoCentryx, Inc.CCXI 6,531,733, disposed Open Form 4 filing 0001209191-22-044896
2020-12-15 S, Open-market sale ChemoCentryx, Inc.CCXI 1,145,450, disposed Open Form 4 filing 0001209191-20-063919
2020-12-14 S, Open-market sale ChemoCentryx, Inc.CCXI 725,246, disposed Open Form 4 filing 0001209191-20-063919
2020-06-15 S, Open-market sale ChemoCentryx, Inc.CCXI 130,090, disposed Open Form 4 filing 0001209191-20-037135
2020-06-12 S, Open-market sale ChemoCentryx, Inc.CCXI 5,775,877, disposed Open Form 4 filing 0001209191-20-037135
2020-05-12 S, Open-market sale ChemoCentryx, Inc.CCXI 2,071,100, disposed Open Form 4 filing 0001209191-20-028669
2020-05-11 S, Open-market sale ChemoCentryx, Inc.CCXI 2 lines 3,919,731, disposed Open Form 4 filing 0001209191-20-028669
2020-05-08 S, Open-market sale ChemoCentryx, Inc.CCXI 231,115, disposed Open Form 4 filing 0001209191-20-028669
2020-05-05 S, Open-market sale ChemoCentryx, Inc.CCXI 486,851, disposed Open Form 4 filing 0001209191-20-027817
2020-03-04 S, Open-market sale ChemoCentryx, Inc.CCXI 2,056,691, disposed Open Form 4 filing 0001209191-20-016765
2020-02-20 S, Open-market sale ChemoCentryx, Inc.CCXI 2 lines 770,296, disposed Open Form 4 filing 0001209191-20-011796
2020-02-19 S, Open-market sale ChemoCentryx, Inc.CCXI 2 lines 3,198,514, disposed Open Form 4 filing 0001209191-20-011796
2020-02-04 S, Open-market sale ChemoCentryx, Inc.CCXI 5,400,701, disposed Open Form 4 filing 0001209191-20-007294
2020-01-17 S, Open-market sale ChemoCentryx, Inc.CCXI 2 lines 4,398,272, disposed Open Form 4 filing 0001209191-20-004185
2020-01-16 S, Open-market sale ChemoCentryx, Inc.CCXI 1,243,170, disposed Open Form 4 filing 0001209191-20-004185
2019-11-26 S, Open-market sale ChemoCentryx, Inc.CCXI 9 lines 8,808,112, disposed Open Form 4 filing 0001209191-19-058382
2019-04-02 S, Open-market sale ChemoCentryx, Inc.CCXI 1,038,909, disposed Open Form 4 filing 0001209191-19-022818
2019-04-01 S, Open-market sale ChemoCentryx, Inc.CCXI 1,076,084, disposed Open Form 4 filing 0001209191-19-022818
2019-03-29 S, Open-market sale ChemoCentryx, Inc.CCXI 80,570, disposed Open Form 4 filing 0001209191-19-022818
2019-01-10 S, Open-market sale ChemoCentryx, Inc.CCXI 447,092, disposed Open Form 4 filing 0001209191-19-003643
2019-01-09 S, Open-market sale ChemoCentryx, Inc.CCXI 154,771, disposed Open Form 4 filing 0001209191-19-003169
2019-01-07 S, Open-market sale ChemoCentryx, Inc.CCXI 87,599, disposed Open Form 4 filing 0001209191-19-003169
2018-11-07 S, Open-market sale ChemoCentryx, Inc.CCXI 86,554, disposed Open Form 4 filing 0001209191-18-058021
2018-06-29 S, Open-market sale ChemoCentryx, Inc.CCXI 1,410, disposed Open Form 4 filing 0001209191-18-040520
2018-06-28 S, Open-market sale ChemoCentryx, Inc.CCXI 150,618, disposed Open Form 4 filing 0001209191-18-040520
2018-05-23 S, Open-market sale ChemoCentryx, Inc.CCXI 363,293, disposed Open Form 4 filing 0001209191-18-032804
2018-05-22 S, Open-market sale ChemoCentryx, Inc.CCXI 402,150, disposed Open Form 4 filing 0001209191-18-032804
2018-05-21 S, Open-market sale ChemoCentryx, Inc.CCXI 2 lines 426,022, disposed Open Form 4 filing 0001209191-18-032804
2018-05-17 S, Open-market sale ChemoCentryx, Inc.CCXI 216,137, disposed Open Form 4 filing 0001209191-18-031204
2018-05-16 S, Open-market sale ChemoCentryx, Inc.CCXI 1,007,665, disposed Open Form 4 filing 0001209191-18-031204
2018-05-15 S, Open-market sale ChemoCentryx, Inc.CCXI 1,132,060, disposed Open Form 4 filing 0001209191-18-031204
2018-05-02 S, Open-market sale ChemoCentryx, Inc.CCXI 362,451, disposed Open Form 4 filing 0001209191-18-027937
2018-05-01 S, Open-market sale ChemoCentryx, Inc.CCXI 188,407, disposed Open Form 4 filing 0001209191-18-027937

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Codes on this page
P, Open-market purchase
Open-market purchase
S, Open-market sale
Open-market sale
Relationships on this page
D, Director
Director

Every value is as reported on the Form 4, totalled to the dollar. Share counts, the price per share and the full list of reporting owners are on each filing's own page, which every row here opens. A row marked n lines adds up that many filed lines of one filing, on one day, on one side of the market; a filing whose lines fall across two pages is left as its lines on both, so no total here is ever short.

What this insider's stored lines contain

Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.

  • Open-market purchase 4
  • Open-market sale 100
  • Option exercise 0
  • Grant or award 0
  • Tax withholding 0
  • Disposition to the issuer 0
  • In-the-money option exercise 0

How to cite this page

ebomi catalog. Schall Thomas J., insider transactions. Retrieved 2026-08-23 from https://ebomi.com/insider/0001423084

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.